Contract facts
UnrestrictedNo full NAICS 325413 intel page yet. Browse NAICS intelligence
In Accordance with FAR 52.232-37, This Call Order Is to Pay for Testing Associated with the Automated Chemistry Testing… is a federal Unrestricted award for Fa8601 Aflcmc Pzio held by Ortho-Clinical Diagnostics, Inc. Estimated value $109K ($109K obligated). Current period of performance ends Oct 28, 2026. Last award drew 1 bidder. Place of performance: DAYTON OH.
In accordance with far 52.232-37, this call order is to pay for testing associated with the automated chemistry testing platform for 88th medical group. Latest action is a modification.
Recompete timing
PublicCurrent PoP ended Oct 28, 2026 (9 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on FA860125F0230? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordOrtho-Clinical Diagnostics, Inc — $57.6M obligated across 1,615 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract FA860125F0230?
FA860125F0230 (Accordance with FAR 52.232-37 this call) is a Fa8601 Aflcmc Pzio award with a potential value of $109K, currently held by Ortho-Clinical Diagnostics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is FA8601-25-F-0230?
FA8601-25-F-0230 is the dashed form of PIID FA860125F0230 (Accordance with FAR 52.232-37 this call), held by Ortho-Clinical Diagnostics, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded FA860125F0230?
Fa8601 Aflcmc Pzio awarded FA860125F0230 to Ortho-Clinical Diagnostics, Inc (potential $109K).
Who is the incumbent on FA860125F0230?
Ortho-Clinical Diagnostics, Inc is the incumbent with $57.6M across 1615 related awards in SCOUT’s public footprint. The current period of performance ends Oct 28, 2026.
When does Ortho-Clinical Diagnostics, Inc’s FA860125F0230 come up for recompete?
SCOUT tracks a period-of-performance end of Oct 28, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on FA860125F0230? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.